Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Jun;34(6):1254–1256. doi: 10.1128/aac.34.6.1254

Influence of lomefloxacin on the pharmacokinetics of theophylline.

M LeBel 1, F Vallée 1, M St-Laurent 1
PMCID: PMC171794  PMID: 2393286

Abstract

The effect of multiple doses of lomefloxacin (400 mg twice a day) on the clearance of theophylline and the urinary excretion of its metabolites was investigated in 15 healthy male subjects. Concentrations of theophylline in plasma were measured by TDx (Abbott Diagnostics, Mississauga, Ontario, Canada). Urinary excretion of theophylline and its three major metabolites and lomefloxacin in plasma were assayed by high-performance liquid chromatography. Total theophylline clearance remained unchanged before lomefloxacin treatment and after lomefloxacin single- and multiple-dose treatments (58.02, 56.57, 54.07 ml/min, respectively). The urinary recovery of unchanged theophylline and its major metabolites stayed stable during the study. We conclude that lomefloxacin can be added to the list of fluoroquinolones that can be administered safely with theophylline.

Full text

PDF
1256

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beckmann J., Elsässer W., Gundert-Remy U., Hertrampf R. Enoxacin--a potent inhibitor of theophylline metabolism. Eur J Clin Pharmacol. 1987;33(3):227–230. doi: 10.1007/BF00637553. [DOI] [PubMed] [Google Scholar]
  2. Dunne A. JANA: a new iterative polyexponential curve stripping program. Comput Methods Programs Biomed. 1985 Aug;20(3):269–275. doi: 10.1016/0169-2607(85)90085-9. [DOI] [PubMed] [Google Scholar]
  3. Edwards D. J., Bowles S. K., Svensson C. K., Rybak M. J. Inhibition of drug metabolism by quinolone antibiotics. Clin Pharmacokinet. 1988 Sep;15(3):194–204. doi: 10.2165/00003088-198815030-00004. [DOI] [PubMed] [Google Scholar]
  4. Kester M. B., Saccar C. L., Rocci M. L., Jr, Mansmann H. C., Jr New simplified microassay for the quantitation of theophylline and its major metabolites in serum by high-performance liquid chromatography. J Chromatogr. 1986 Jul 11;380(1):99–108. doi: 10.1016/s0378-4347(00)83628-2. [DOI] [PubMed] [Google Scholar]
  5. Nix D. E., Norman A., Schentag J. J. Effect of lomefloxacin on theophylline pharmacokinetics. Antimicrob Agents Chemother. 1989 Jul;33(7):1006–1008. doi: 10.1128/aac.33.7.1006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Parent M., St-Laurent M., LeBel M. Safety of fleroxacin coadministered with theophylline to young and elderly volunteers. Antimicrob Agents Chemother. 1990 Jun;34(6):1249–1253. doi: 10.1128/aac.34.6.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Staib A. H., Harder S., Fuhr U., Wack C. Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid. Int J Clin Pharmacol Ther Toxicol. 1989 Jun;27(6):289–283. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES